Abstract
“An untroubled mind, no longer seeking to consider what is right and what is wrong; A mind beyond judgements, watches and understands.” The Buddha (translated from the Dhammapada ) The purpose of this article is to describe our personal experience in translating observations made in the experimental laboratory using MCE into the clinical setting. It is not intended to be an exhaustive review of MCE, for which readers are referred elsewhere.1 2 3 The work of others in MCE and related subjects will be mentioned only when it has influenced our own work. Our bench-to-bedside experience with MCE over the past 15 years will be discussed under these six broad categories: (a) technical issues; (b) AMI, (c) detection of CAD, (d) applications in the operating room, (e) quantification of myocardial perfusion, and (f) work in progress. Historically, it has not been possible to directly assess myocardial perfusion with echocardiography. Its clinical focus has involved the evaluation of cardiac chamber size and function, valve morphology and kinetics, pericardial space and great vessels, and intracavitary blood flow velocities. Yet, echocardiography is highly suited for the evaluation of myocardial perfusion for the following reasons: (a) It has very good spatial resolution (<1 mm in the axial direction), which is far superior to that offered by SPECT and positron emission tomography, although not as good as magnetic resonance imaging and ultrafast cine computed tomography; (b) its temporal resolution is excellent (30 to 120 Hz) and exceeds that of other commonly used imaging technologies; (c) for an imaging modality, it is inexpensive and has low overhead costs; (d) it is an integral tool in the day-to-day activities of clinical cardiologists, who can obtain advanced training in its use without needing to learn an entirely new technology. The study of myocardial perfusion with echocardiography involves …

This publication has 50 references indexed in Scilit: